Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Prinses Máxima Centrum Voorpagina
Nederlands
English
Content zoeken bij Prinses Máxima Centrum
Voorpagina
Profielen
Onderzoeksgroepen
Uitrusting
Onderzoeksoutput
Prijzen
Activiteiten
Knipsels
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
Marc Remke
, Thomas Hielscher
, Andrey Korshunov
, Paul A. Northcott
, Sebastian Bender
,
Marcel Kool
, Frank Westermann
, Axel Benner
, Huriye Cin
, Marina Ryzhova
, Dominik Sturm
, Hendrik Witt
, Daniel Haag
, Grischa Toedt
, Andrea Wittmann
, Anna Schöttler
, André O. Von Bueren
, Andreas Von Deimling
, Stefan Rutkowski
, Wolfram Scheurlen
Andreas E. Kulozik, Michael D. Taylor, Peter Lichter, Stefan M. Pfister
Toon overzicht 4 andere
Toon minder
Onderzoeksoutput
:
Bijdrage aan tijdschrift
›
Artikel
›
peer review
147
Citaten (Scopus)
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
Bioinformatics Tools
14%
Clinical Heterogeneity
14%
Clinical Trials
14%
Copy number Analysis
14%
Cost-effective Tool
14%
Differentially Expressed Transcripts
14%
Dismal Prognosis
28%
DNA Copy number
14%
Early Treatment
14%
Effective Treatment
14%
Expression Pattern
14%
Follistatin
100%
Genetic Modification
14%
Genomic Approaches
14%
Good Prognosis
14%
High Risk
28%
Immunohistochemistry
14%
Immunopositivity
28%
Integrated Genomics
14%
Intermediate Risk
14%
Large Cohort
14%
Marker Genes
14%
Medulloblastoma
71%
Medulloblastoma Subgroups
14%
Molecular Biomarkers
14%
Molecular Stratification
14%
Molecular Subgrouping
14%
Molecular Subgroups
14%
Molecular Variants
14%
Non-overlapping
14%
Patient Cohort
14%
Poor Prognosis
100%
Prognostic Power
14%
Prognostic Value
14%
Quantitative PCR
14%
Risk for Relapse
14%
Screening Population
14%
Sonic Hedgehog
42%
Sonic Hedgehog Medulloblastoma
100%
Stable Groups
14%
Tissue Microarray
14%
Transcriptome
14%
Transcriptomics
14%
Treatment Stratification
14%
Tumor
42%
Neuroscience
Follistatin
100%
Gene Dosage
14%
Gene Mutation
14%
Immunohistochemistry
14%
Marker Gene
14%
Medulloblastoma
100%
Microarrays
14%
Real-Time Polymerase Chain Reaction
14%
Sonic Hedgehog
100%
Transcriptome
14%
Transcriptomics
14%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
14%
Copy Number Analysis
14%
Follistatin
100%
Gene Dosage
14%
Gene Mutation
14%
Genomics
14%
Marker Gene
14%
Real-Time Polymerase Chain Reaction
14%
Sonic Hedgehog
100%
Tissue Microarray
14%
Transcriptome
14%
Transcriptomics
14%